Skip to main content

Table 3 Number of reports and crude reporting odds ratio of acute kidney injury associated with anti-infectives

From: Pharmacovigilance study of anti-infective-related acute kidney injury using the Japanese adverse drug event report database

Classification (ATC code)

Total (n)

Case (n)

Crude RORa (95% CIb)

Total

534,688

21,727

 

Antibacterials

 Tetracyclines (J01AA)

1763

75

1.05 (0.83–1.32)

 Amphenicols (J01BA)

49

0

c

 Penicillins with extended spectrum (J01CA)

3264

121

0.91 (0.76–1.09)

 Beta-lactamase sensitive penicillins (J01CE)

93

6

1.63 (0.71–3.72)

 Beta-lactamase resistant penicillins (J01CF)

0

0

c

 Beta-lactamase inhibitors (J01CG)

0

0

c

 Combinations of penicillins, incl. Beta-lactamase inhibitors (J01CR)

2121

292

3.81 (3.36–4.31)d

 First-generation cephalosporins (J01DB)

1484

46

0.75 (0.56–1.01)

 Second-generation cephalosporins (J01DC)

1902

101

1.33 (1.08–1.62)d

 Third-generation cephalosporins (J01DD)

7551

341

1.12 (1.002–1.25)d

 Fourth-generation cephalosporins (J01DE)

1318

128

2.55 (2.12–3.06)d

 Monobactams (J01DF)

21

4

5.56 (1.87–16.51)d

 Carbapenems (J01DH)

3551

313

2.30 (2.05–2.59)d

 Other cephalosporins and penems (J01DI)

132

9

1.73 (0.88–3.40)

 Trimethoprim and derivatives (J01EA)

0

0

c

 Intermediate-acting sulfonamides (J01EC)

36

7

5.70 (2.50–13.01)d

 Long-acting sulfonamides (J01ED)

4

0

c

 Combinations of sulfonamides and trimethoprim, incl. Derivatives (J01EE)

2738

261

2.51 (2.20–2.85)d

 Macrolides (J01FA)

5283

200

0.93 (0.81–1.07)

 Lincosamides (J01FF)

757

55

1.85 (1.41–2.44)d

 Streptogramins (J01FG)

2

0

c

 Streptomycins (J01GA)

153

9

1.48 (0.75–2.89)

 Other aminoglycosides (J01GB)

932

258

9.13 (7.91–10.55)d

 Fluoroquinolones (J01MA)

8571

494

1.45 (1.33–1.59)d

 Other quinolones (J01MB)

24

3

3.37 (1.01–11.31)d

 Combinations of antibacterials (J01RA)

638

11

0.41 (0.23–0.75)

 Glycopeptide antibacterials (J01XA)

2752

596

6.68 (6.10–7.32)d

 Polymyxins (J01XB)

137

107

84.62 (56.43–126.89)d

 Steroid antibacterials (J01XC)

2

0

c

 Imidazole derivatives (J01XD)

667

12

0.43 (0.24–0.77)

 Nitrofuran derivatives (J01XE)

0

0

c

 Other antibacterials (J01XX)

2119

107

1.26 (1.03–1.53)d

Antimycotics

 Antibiotics (J02AA)

1337

299

6.88 (6.05–7.83)d

 Imidazole derivatives (J02AB)

100

1

c

 Triazole derivatives (J02AC)

3130

315

2.67 (2.37–3.00)d

 Other antimycotics for systemic use (J02AX)

1148

161

3.87 (3.28–4.58)d

  1. a Reporting Odds Ratio, b Confidence Interval, c Number of cases < 2, d Lower limit of 95% CI > 1